Inventor · disambiguated record
David Pacenti
Also filed as: PACENTI DAVID · PACENTI DAVID P
3 granted patents·7 pending applications·2 citations·filing 2007–2024
53Inventor score
Top patents by PatentIndex Score
10 records- 0182US11169159B2Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in bloodABBOTT LAB·Filed 2018·Granted Nov 9, 2021·2 cites·14 claims
- 0280US2024402195A1Methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in bloodABBOTT LAB·Filed 2024·Application pending·0 cites
- 0371US12123883B2Methods for measuring ubiquitin carboxy—terminal hydrolase L1 levels in bloodABBOTT LAB·Filed 2021·Granted Oct 22, 2024·0 cites·15 claims
- 0470US2022050111A1Methods for aiding in the diagnosis of traumatic injury by meauring at least one biomarker that is uch-l1ABBOTT LAB·Filed 2021·Application pending·0 cites
- 0570US2022003786A1Methods for aiding in the diagnosis of a traumatic brain injury by measuring at least one biomarker that is gfapABBOTT LAB·Filed 2021·Application pending·0 cites
- 0663US2018106818A1Methods of assessing gfap status in patient samplesABBOTT LAB·Filed 2017·Application pending·0 cites
- 0759US2018106800A1Methods of assessing uch-l1 status in patient samplesABBOTT LAB·Filed 2017·Application pending·0 cites
- 0855US2009148866A1Antibodies and Improved Test Sample Handling Methods for Use in Assays for MyeloperoxidaseABBOTT LAB·Filed 2008·Application pending·0 cites
- 0938US2008286818A1Blood sample handling methods for improved assays for myeloperoxidaseDATWYLER SAUL A·Filed 2007·Application pending·0 cites
- 1032US8288111B2Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolitesBRATE ELAINE M·Filed 2008·Granted Oct 16, 2012·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when David Pacenti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →